www.praktickelekarenstvi.cz e36 / Klin Farmakol Farm 2022;36(1):29-33 / PRAKTICKÉ LÉKÁRENSTVÍ NEMOCNIČNÍ LÉKÁRENSTVÍ Fyzikálně-chemické vlastnosti kolistinu a jejich dopady do klinické praxe 25. Markou N, Markantonis SL, Dimitrakis E et al. Colistin serum concentrations after intrave‑ nous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study. Clin Ther. 2008;30(1):143-151. 26. Menna P, Salvatorelli E, Mattei A, Cappiello D, Minotti G, Carassiti M. Modified Colistin Regimen for Critically Ill Patients with Acute Renal Impairment and Continuous Renal Re‑ placement Therapy. Chemotherapy. 2018;63(1):35-38. 27. Dudhani RV, Nation RL, Li J. Evaluating the stability of colistin and colistin methanesul‑ phonate in human plasma under different conditions of storage. J Antimicrob Chemother. 2010;65(7):1412-1415. 28. Gobin P, Lemaître F, Marchand S, Couet W, Olivier JC. Assay of colistin and colistin metha‑ nesulfonate in plasma and urine by liquid chromatography-tandem mass spectrometry. Antimicrob Agents Chemother. 2010;54(5):1941-1948. 29. Hanai Y, Matsuo K, Kosugi T et al. Rapid, simple, and clinically applicable high-perfor‑ mance liquid chromatography method for clinical determination of plasma colistin con‑ centrations. J Pharm Health Care Sci. 2018;4(22). 30. Binhashim NH, Alvi SN, Hammami MM. LC-MS/MS Method for Determination of Coli‑ stin in Human Plasma: Validation and Stability Studies. International Journal of Analytical Mass Spectrometry and Chromatography. 2021;9(1). 31. Karvanen M, Malmberg C, Lagerbäck P, Friberg LE, Cars O. Colistin Is Extensively Lost during Standard In Vitro Experimental Conditions. Antimicrob Agents Chemother. 2017;61(11):e00857-17. 32. Dagla I, Karkoula E, Baira E, Tsarbopoulos A, Gikas E. Analytical methodologies used for the determination of colistin in biological fluids. Is it still a challenge? J Pharmaceut Bio‑ med. 2019;164:777-788. 33. Zabidi MS, Abu Bakar R, Musa N, Wan Yusuf WN. Analytical methodologies for mea‑ suring colistin levels in pharmacokinetic studies. J Liq Chromatogr Relat. 2020;43:671-686. 34. Qi B, Gijsen M, Van Brantegem P, De Vocht T, Deferm N, Abza GB, Nauwelaerts N, Wau‑ ters J, Spriet I, Annaert P. Quantitative determination of colistin A/B and colistin methan‑ esulfonate in biological samples using hydrophilic interaction chromatography tandem mass spectrometry. Drug Test Anal. 2020;12:1183-1195. 35. Leporati M, Bua RO, Mariano F, Carignano P, Stella M, Biancone L, Vincenti M. Determina‑ tion by LC–MS/MS of Colistins A and B in Plasma and Ultrafiltrate From Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration. Ther Drug Monit. 2014;36(2):182-191. 36. Yuan H, Yu S, Chai G, Liu J, Zhou Q (Tony). A LC-MS/MS method for simultaneous ana‑ lysis of the cystic fibrosis therapeutic drugs colistin, ivacaftor and ciprofloxacin. J Pharm Anal. 2021;11(6):732-738. 37. Peng C, Zuo S, Qiu Y, Fu S, Peng L. Determination of Colistin in Contents Derived from Gastrointestinal Tract of Feeding Treated Piglet and Broiler. Antibiotics. 2021;10(4):422. 38. Binhashim NH, Alvi SN, Hammami MM. LC-MS/MS Method for Determination of Coli‑ stin in Human Plasma: Validation and Stability Studies. Int J Anal Mass Spectrom Chroma‑ togr. 2021;9:1-11. 39. Zhao M, Wu X-J, Fan Y-X, Guo B-N, Zhang J. Development and validation of a UHPLC– MS/MS assay for colistin methanesulphonate (CMS) and colistin in human plasma and urine using weak-cation exchange solid-phase extraction. J Pharmaceut Biomed. 2016;124:303-308. 40. Cangemi G, Barco S, Castagnola E, Tripodi G, Favata F, D’Avolio A. Development and validation of UHPLC–MS/MS methods for the quantification of colistin in plasma and dried plasma spots. J Pharmaceut Biomed. 2016;129:551-557. 41. Bihan K, Lu Q, Enjalbert M, Apparuit M, Langeron O, Rouby J-J, Funck-Brentano C, Zahr N. Determination of Colistin and Colistimethate Levels in Human Plasma and Urine by Hi‑ gh-Performance Liquid Chromatography–Tandem Mass Spectrometry. Ther Drug Monit. 2016;38(6):796-803. 42. Gaugain M, Raynaud A, Bourcier S, Verdon E, Hurtaud-Pessel D. Development of a liquid chromatography-tandem mass spectrometry method to determine colistin, bacitracin and virginiamycin M1 at cross-contamination levels in animal feed. Food Addit Contam A. 2021;38(9):1481-1494.
RkJQdWJsaXNoZXIy NDA4Mjc=